Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2

Molecular Biology of the Cell

Volumn 16, Issue 3, 2005, Pages 1513-1526

  Adamson, Aaron W ^a,d   Beardsley, Dillon I ^a,b   Kim, Wan Ju ^b   Gao, Yajuan ^c   Baskaran, R ^c   Brown, Kevin D ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; METHYLNITRONITROSOGUANIDINE; NITROSOUREA DERIVATIVE; PROTEIN CDC25C; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DOSE RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MISMATCH REPAIR; MITOSIS INHIBITION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; RNA INTERFERENCE;

BASE PAIR MISMATCH; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; G2 PHASE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METHYLNITRONITROSOGUANIDINE; MUTS HOMOLOG 2 PROTEIN; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAUROSPORINE; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 14844331767     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-02-0089     Document Type: Article

References (74)

1. Abraham, R. T. (2001). Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196.
2. Adamson, A. W., Kim, W. J., Shangary, S., Baskaran, R., and Brown, K. D. (2002). ATM is activated in response to N-methyl-N′-nitro-N- nitrosoguanidine-induced DNA alkylation. J. Biol. Chem. 277, 38222-38229.
3. Aebi, S., et al. (1996). Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56, 3087-3090.
4. Ahn, J. Y., Schwarz, J. K., Piwnica-Worms, H., and Canman, C. E. (2000). Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60, 5934-5936.
5. Alien, D. M., et al. (2001). Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev. 15, 554-566.
6. Baber-Furnari, B. A., Rhind, N., Boddy, M. N., Shanahan, P., Lopez-Girona, A., and Russell, P. (2000). Regulation of mitotic inhibitor mikl helps to enforce the DNA damage checkpoint. Mol. Biol. Cell 11, 1-11.
7. Bakkenist, C. J., and Kastan, M. B. (2003). DNA damage activates ATM through rntermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506.
8. Boddy, M. N., Furnari, B., Mondesert, O., and Russell, P. (1998). Replication checkpoint enforced by kinases Cds1 and Chk1. Science 280, 909-912.
9. Branch, P., Aquilina, G., Bignami, M., and Karran, P. (1993). Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362, 652-654.
10. Brown, A. L., Lee, C. H., Schwarz, J. K., Mitiku, N., Piwnica-Worms, H., and Chung, J. H. (1999). A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 96, 3745-3750.
11. Brown, K. D., Rathi, A., Kamath, R., Beardsley, D. I., Zhan, Q., Mannino, J. L., and Baskaran, R. (2003). The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 33, 80-84.
12. Cejka, P., Stojic, L., Mojas, N., Russell, A. M., Heinimann, K., Cannavo, E., di Pietro, M., Marra, G., and Jiricny, J. (2003). Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J. 22, 2245-2254.
13. Chaturvedi, P., et al. (1999). Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047-4054.
14. Christensen, P. U., Bentley, N. J., Martinho, R. G., Nielsen, O., and Carr, A. M. (2000). Mik1 levels accumulate in S phase and may mediate an intrinsic link between S phase and mitosis. Proc. Natl. Acad. Sci. USA 97, 2579-2584.
15. Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., and Friend, S. H. (1998). Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17, 159-169.
16. Dalal, S. N., Schweitzer, C. M., Gan, J., and DeCaprio, J. A. (1999). Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol. Cell. Biol. 19, 4465-4479.
17. Dolan, M. E., Moschel, R. C., and Pegg, A. E. (1990). Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA 87, 5368-5372.
18. Drotschmann, K., Topping, R .P., Clodfelter, J. E., and Salsbury, F. R. (2004). Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair 3, 729-742.
19. Duckett, D. R., Bronstein, S. M., Taya, Y., and Modrich, P. (1999). hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl. Acad. Sci. USA 96, 12384-12388.
20. Duckett, D. R., Drummond, J. T., Murchie, A. I., Reardon, J. T., Sancar, A., Lilley, D. M., and Modrich, P. (1996). Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA 93, 6443-6447.
21. Falck, J., Mailand, N., Syljuasen, R. G., Bartek, J., and Lukas, J. (2001). The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-847.
22. Falck, J., Petrini, J. H., Williams, B. R., Lukas, J., and Bartek, J. (2002). The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30, 290-294.
23. Goldmacher, V. S., Cuzick, R. A., Jr., and Thilly, W. G. (1986). Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine. J. Biol. Chem. 262, 12462-12471.
24. Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., and Piwnica-Worms, H. (2000). The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275, 5600-5605.
25. Griffin, S., Branch, P., Xu, Y. Z., and Karran, P. (1994). DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry 33, 4787-4793.
26. Hagting, A., Karlsson, C., Clute, P., Jackman, M., and Pines, J. (1998). MPF localization is controlled by nuclear export. EMBO J. 17, 4127-4138.
27. Hartwell, L. H., and Kastan, M. B. (1994). Cell cycle control and cancer. Science 266, 1821-1828.
28. Hirose, Y., Katayama, M., Stokoe, D., Haas-Kogan, D. A., Berger, M. S., and Pieper, R. O. (2003). The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol. Cell. Biol. 23, 8306-8315.
29. Jaiswal, A. S., Multani, A. S., Pathak, S., and Narayan, S. (2004). N-Methyl-N′-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA. Mol. Cancer 3, 3.
30. Jallepalli, P. V., Lengauer, C., Vogelstein, B., and Bunz, F. (2003). The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278, 20475-20479.
31. Kalamegham, R., Warmels-Rodenhiser, S., MacDonald, H., and Ebisuzaki, K. (1988). O6-Methylguanine-DNA methyltransferase-defective human cell mutant: O6-methylguanine, DNA strand breaks and cytotoxicity. Carcinogenesis 9, 1749-1753.
32. Karran, P., and Bignami, M. (1992). Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res. 20, 2933-2940.
33. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
34. Kat, A., Thilly, W. G., Fang, W. H., Longley, M. J., Li, G. M., and Modrich, P. (1993). An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA 90, 6424-6428.
35. Kaufmann, W. K., and Wilson, S. J. (1994). G1 arrest and cell-cycle-dependent clastogenesis in UV-irradiated human fibroblasts. Mutat, Res. 314, 67-76.
36. Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., Carethers, J, M., Kunkel, T. A., and Boland, C. R. (1994). Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 54, 4308-4312.
37. Lee, M. S., Ogg, S., Xu, M., Parker, L. L., Donoghue, D. J., Maller, J. L., and Piwnica-Worms, H. (1992). cdc254- encodes a protein phosphatase that dephosphorylates p34cdc2. Mol. Biol. Cell 3, 73-84.
38. Lin, D. P., et al. (2004). An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res. 64, 517-522.
39. Lindahl, T., Demple, B., and Robins, P. (1982). Suicide inactivation of the E. coli O6-methylguanine-DNA methyltransferase. EMBO J. 1, 1359-1363.
40. Liu, F., Rothblum-Oviatt, C., Ryan, C. E., and Piwnica-Worms, H. (1999). Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-Cyclin B1 complexes. Mol. Cell. Biol. 19, 5113-5123.
41. Liu, Q., et al. (2000). Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14, 1448-1459.
42. Loeb, L. A., Loeb, K. R., and Anderson, J. P. (2003). Multiple mutations and cancer. Proc. Natl. Acad. Sci. USA 100, 776-781.
43. Lundgren, K., Walworth, N., Booher, R., Dembski, M., Kirschner, M., and Beach, D. (1991). mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 64, 1111-1122.
44. Mailand, N., Falck, J., Lukas, C., Syljuasen, R. G., Welcker, M., Bartek, J., and Lukas, J. (2000). Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429.
45. Mailand, N., Podtelejnikov, A. V., Groth, A., Mann, M., Bartek, J., and Lukas, J. (2002). Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21, 5911-5920.
46. Matsuoka, S., Huang, M., and Elledge, S. J. (1998). Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-1897.
47. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., and Elledge, S. J. (2000). Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97, 10389-10394.
48. Mello, J. A., Acharya, S., Fishel, R., and Essigmann, J. M. (1996). The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3, 579-589.
49. Ohi, R., and Gould, K. L. (1999). Regulating the onset of mitosis. Curr. Opin. Cell Biol. 11, 267-273.
50. Paddison, P. J., Caudy, A. A., Sachidanandam, R., and Hannon, G. J. (2004). Short hairpin activated gene silencing in Mammalian cells. Methods Mol. Biol. 265, 85-100.
51. Papadopoulos, N., et al. (1994). Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625-1629.
52. Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsry, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., and Kaufmann, W. K. (1995). Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 55, 1763-1773.
53. Peng, C. Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., and Piwnica-Worms, H. (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
54. Plant, J. E., and Roberts, J. J. (1971). Extension of the pre-DNA synthetic phase of the cell cycle as a consequence of DNA alkylation in Chinese hamster cells: a possible mechanism of DNA repair. Chem. Biol. Interact. 3, 343-351.
55. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., and Elledge, S. J. (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497-1501.
56. Sarkaria, J. N., Busby, E. C., Tibbetts, R. S., Roos, P., Taya, Y., Karnitz, L. M., and Abraham, R. T. (1999). Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375-4382.
57. Stojic, L., Mojas, N., Cejka, P., Di Pietro, M., Ferrari, S., Marra, G., and Jiricny, J. (2004). Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 18, 1331-1344.
58. Strausfeld, U., Labbe, J. C., Fesquet, D., Cavadore, J. C., Picard, A., Sadhu, K., Russell, P., and Doree, M. (1991). Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 351, 242-245.
59. Umar, A., Koi, M., Risinger, J. I., Glaab, W. E., Tindall, K. R., Kolodner, R. D., Boland, C. R., Barrett, J. C., and Kunkel, T. A. (1997). Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 57, 3949-3955.
60. Walsh, S., Margolis, S. S., and Kornbluth, S. (2003). Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. Mol. Cancer Res. 1, 280-289.
61. Wang, X., McGowan, C. H., Zhao, M., He, L., Downey, J. S., Fearns, C., Wang, Y., Huang, S., and Han, J. (2000). Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20, 4543-4552.
62. Wang, Y., and Qin, J. (2003). MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc. Natl. Acad. Sci. USA
63. Wright, J. A., Keegan, K. S., Herendeen, D. R., Bentley, N. J., Carr, A. M., Hoekstra, M. F., and Concannon, P. (1998). Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc. Natl. Acad. Sci. USA 95, 7445-7450.
64. Xiao, Z., Chen, Z., Gunasekera, A. H., Sowin, T. J., Rosenberg, S. H., Fesik, S., and Zhang, H. (2003). Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents. J. Biol. Chem. 278, 21767-21773.
65. Xu, B., Kim, S. T., Lim, D. S., and Kastan, M. B. (2002). Two molecularly distinct g(2)/m checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 22, 1049-1059.
66. Yang, J., Bardes, E. S., Moore, J. D., Brennan, J., Powers, M. A., and Kornbluth, S. (1998). Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev. 12, 2131-2143.
67. Yang, J., Song, H., Walsh, S., Bardes, E. S., and Kornbluth, S. (2001). Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites. J. Biol. Chem. 276, 3604-3609.
68. Yu, Q., La Rose, J., Zhang, H., Takemura, H., Kohn, K. W., and Pommier, Y. (2002). UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation- induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. Cancer Res. 62, 5743-5748.
69. Zampetti-Bosseler, F., and Scott, D. (1981). Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation. Int. J. Radiat. Biol. Relat. Stud Phys. Chem. Med. 39, 547-558.
70. Zhao, H., and Piwnica-Worms, H. (2001). ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 22, 4129-4139.
71. Zhao, H., Watkins, J. L., and Piwnica-Worms, H. (2002). Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. USA 99, 14795-14800.
72. Zhou, B. B., Chaturvedi, P., Spring, K., Scott, S. P., Johanson, R. A., Mishra, R., Mattern, M. R., Winkler, J. D., and Khanna, K. K. (2000). Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275, 10342-10348.
73. Zhukovskaya, N., Branch, P., Aquilina, G., and Karran, P. (1994). DNA replication arrest and tolerance to DNA methylation damage. Carcinogenesis 15, 2189-2194.
74. Ziv, Y., Bar-Shira, A., Pecker, I., Russell, P., Jorgensen, T. J., Tsarfati, I., and Shiloh, Y. (1997). Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 25, 159-167.